Clinical Trials

If you are a candidate for a clinical trial, you will be approached by a member of our interventional cardiology team. Our clinical coordinators are usually involved in screening and enrolling patients in clinical trials.

Now Recruiting:

SYMPLICITY HTN-3 Trial: "Renal Denervation in Patients with Uncontrolled Hypertension"

Targeted population: Patients with uncontrolled hypertension.

EXCEL Trial: "Evaluation of XIENCE PRIME or XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization"

Targeted population: Patients with unprotected left main coronary artery disease.

TRYTON Trial: "Randomized Bifurcation Stent Trial"

Targeted population: Patients with symptomatic, ishemic heart disease due to stenotic bifurcation lesion in a native coronary artery.

PARTNER II Trial: Placement of Aortic Transcatheter Valves Trial II

"The Safety and Effectiveness of the SAPIEN XT Transcatheter Heart Valve with NovaFlex and Ascendra/Ascendra 2 Delivery Systems in Intermediate Risk for Aortic Valve Surgery and Patients Who Cannot Undergo Surgery"

Targeted patient population: Patients with severe aortic valve stenosis.

Closed Trials:

PARTNER I Trial: "Transcatheter Aortic Valve Replacement"

Targeted patient population: Patients with severe aortic valve stenosis.

FAME I Trial: "Fractional Flow Reserve Versus Angiography for Multivessel Evaluation"

Targeted population: Patients with multivessel coronary artery disease.

FAME II Trial: "Fractional Flow Reserve-Guided Percutaneous Coronary Intervention plus Optimal Medical Treatment versus Optimal Medical Treatment Alone in Patients with stable Coronary Artery Disease"

Targeted patient population: Patients with stable coronary artery disease.

Stanford Medicine Resources:

Footer Links: